vimarsana.com

Page 17 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 vaccine: Serum Institute produces 10 80 crore Covishield doses in June

COVID-19 vaccine: Serum Institute produces 10.80 crore Covishield doses in June According to information provided by the Pune-based Serum Institute of India, it has sent 45 batches of Covishield, amounting to 10.80 crore doses, to the Central Drugs Laboratory, Kasauli for release in June so far Covishield manufactured by Serum Institute of India PTI Updated Jun 28, 2021, 8:31 AM IST Fulfilling its commitment, Serum Institute of India has produced over 10 crore doses of its Covid-19 vaccine Covishield in June so far as India ramps up the pace of its vaccination drive in the face of a possible third wave of the viral infection. India s Covid-19 inoculation drive has picked up pace under the new phase of universalisation of Covid-19 vaccination that commenced on June 21 with around 69 lakh vaccine doses being administered on an average daily in the last six days.

Travel to Europe still a worry as India-made Covishield yet to get European Union Green Pass

Highlights The majority of people in India have received Covishield jabs. Even though Covishield has the WHO’s approval, the ‘Green Pass’ program only accommodates EMA-approved vaccines. New Delhi: The recipients of the Covishield vaccine may not be eligible for Europe’s new ‘vaccine passport’ programme, which recognises a few COVID-19 vaccines whose recipients will be able to travel in and out of Europe with fewer roadblocks than others. The European Union has come up with the concept of Green Pass, which is an immunity document that is meant to ease travel within and to the bloc. Currently, the European Medicines Agency (EMA) has approved only four COVID-19 vaccines for the programme and Covishield vaccine, developed by the Pune-based Serum Institute of India (SII), is not on the list. 

Covishield Yet To Get European Union Green Pass : SII CEO Adar Poonawalla Assures, Hope to Resolve Matter Soon

Covishield Yet To Get European Union Green Pass : SII CEO Adar Poonawalla Assures, Hope to Resolve Matter Soon India.com 19 hours ago © Rajashree Seal | India.com News Desk New Delhi: Soon after reports that Indian travelers vaccinated with Pune-based Serum Institute s Covishield, may not be eligible for the European Union s Green Pass surfaced, SII CEO Adar Poonawalla on Monday took to Twitter and said that he is aware of the matter and assured the people that he will take this matter at the highest levels and resolve it soon. He wrote, I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the E.U., I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries.

Serum Institute CEO Adar Poonawalla breaks silence on India s Covishield yet to get European Union Green Pass

Serum Institute CEO Adar Poonawalla breaks silence on India’s Covishield yet to get European Union ‘Green Pass’ Serum Institute CEO Adar Poonawalla breaks silence on India’s Covishield yet to get European Union ‘Green Pass’ Indians who are vaccinated with the Covishield may not be eligible for the European Union’s Green Pass , according to reports. Share Updated: Jun 28, 2021, 11:18 AM IST Amid reports that Indians who are vaccinated with the Covishield may not be eligible for the European Union’s Green Pass , Serum Institute CEO Adar Poonawalla on Monday (June 28) tweeted that he is aware of the matter and asserted that he will take this matter at the highest levels and resolve this soon.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.